Multimeric Biotherapeutics, Inc.

MegaLigand image

2015 News

1/30/15 - Multimeric Biotherapeutics Chief Scientific Officer to present at protein engineering conference in Boston, May 8, 2015

1/6/15 - Multimeric Biotherapeutics to present at Biotech Showcase

 

2014 News

6/4/14 - Multimeric Biotherapeutics Awarded NCI Grant to advance its immuno-oncology program

3/4/14 - PBS coverage of vaccine research based on Multimeric Biotherapeutics technology

2/28/14 - Video interview of Dr. Geoffrey Stone describing new vaccine research based on Multimeric Biotherapeutics technology

2/27/14 - Front page Miami Herald article features new vaccine research based on Multimeric Biotherapeutics technology

1/27/14 - Multimeric Biotherapeutics Technology Used in New Vaccine Research

2013 News
8/6/13 - Multimeric Biotherapeutics awarded NIH SBIR Phase I grant

2012 News

11/7/12 - Multimeric Biotherapeutics selected as a Semi-Finalist in PitchFest VC competition
9/25/12 - Multimeric Biotherapeutics, Inc. announces issuance of Japan patent for the MegaLigands
7/23/12 - Cancer treatment using CD40 ligand highlighted in scientific journal edited by Multimeric's Chief Scientific Officer

2011 News

12/22/11 - Multimeric Biotherapeutics, Inc. receives an exclusive license to all animal health and reagent uses of its patented multimeric TNF Superfamily ligands

10/28/11 - Topotarget A/S grants Multimeric Biotherapeutics, Inc. an exclusive license to the MegaLigand Platform of TNF Superfamily ligands

8/1/11 - Multimeric Biotherapeutics, Inc. relocates its laboratories to the San Diego Science Center
4/25/11 - Multimeric Biotherapeutics, Inc. obtains an exclusive license to highly active forms of the TNF SuperFamily (TNFSF) molecules using the UltraLigand™ multimerization technology

2010 News

11/15/10 - Multimeric Biotherapeutics receives Stimulus funding from the U.S. Government's QTDP program

4/24/10 - Multimeric Biotherapeutics receives a NIDA grant to develop an innovative nicotine vaccine

4/12/10 - Multimeric Biotherapeutics to present at 2010 BIO International Convention

2009 News

10/12/09 - Preclinical study of Multimeric Biotherapeutic's lead molecule published by PLoS ONE

10/8/09 - VIDEO of Marc Hertz, CEO of Multimeric Biotherapeutics, at the Quick Pitch competition

10/1/09 - Multimeric Biotherapeutics selected to present at Tech Coast Angels' Quick Pitch competition

8/24/09 - Multimeric Biotherapeutics selected to present at BIOCOM Investor Conference

7/22/09 - Multimeric Biotherapeutics announces the issuance of a key patent in Europe

 

2008 News

10/1/08 - Richard Kornbluth becomes Chief Scientific Officer of Multimeric Biotherapeutics, Inc.

2/19/08 - Second US Patent issues for Multimeric Biotherapeutics's lead program

2/8/08 - San Diego company Multimeric Biotherapeutics, Inc. formed as a Delaware C Corp.